Skip to content

Respiratory Complications Among Living Liver-donors

Respiratory Complications Among Living Liver-donors: a Single Center Observational Retrospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03862664
Enrollment
124
Registered
2019-03-05
Start date
2019-02-06
Completion date
2019-05-31
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Anesthesia

Brief summary

Recently, there are increasing reports about pulmonary complications within living liver donors postoperatively. In this retrospective study, the investigators will highlight the risk factors and incidence of pulmonary complication among living liver-donors in our center.

Interventions

The investigators will retrieve retrospectively the medical record of donors who underwent hepatic lobectomy for liver transplantation

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years

Inclusion criteria

* Excellent general physical and mental condition, * Free of chronic disease or * Previous major abdominal surgery, * Body mass index (BMI) \<28, * ABO blood group identical to recipients and * Negative for hepatitis B, C and human immunodeficiency viruses (HIV).

Exclusion criteria

* ASA physical status\> II, * BMI\>28, * Psychiatric or mental retardation, * pregnant and nursing women or * Patients with significant laboratory abnormalities

Design outcomes

Primary

MeasureTime frameDescription
The number of participants with postoperative respiratory complicationsan average period of 3 yearRespiratory complications as pulmonary embolism, pleural effusion, pneumothorax, pneumonia, atelectasis, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and transfusion-related acute lung injury (TRALI) will be considered when they are clinically evident.

Secondary

MeasureTime frameDescription
The average of ICU stay among patientsan average period of 3 yearIt is defined as time period from entry to ICU till discharge to the ward
The average of hospital stay among patientsan average period of 3 yearIt is defined as time period elapsed from discharge to the ward till leaving the hospital

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026